Loperamide
Classification: BATC code: A07DA03
Summary
Controlled studies of differences between men and women are lacking for efficacy, safety, and pharmacokinetic properties for loperamide.
Additional information
Pharmacokinetics and dosing
No studies with a clinically relevant sex analysis regarding the pharmacokinetics or dosing of loperamide have been found.
Effects
No studies with a clinically relevant sex analysis regarding the effects of loperamide have been found.
Adverse effects
No studies with a clinically relevant sex analysis regarding adverse effects of loperamide have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2015-06-02
References
- Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2015 [cited 2016-04-05.] länk
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson